Search the Newsreel

CO2 Energy Transition Shareholders Approve SPAC Extension Plan

ETM Finalises Acquisition of Spain’s Penouta Critical Minerals Mine

Ensign Group director Agwunobi disposes of $67,055 in stock

John O. Agwunobi, a director at The Ensign Group, Inc. (NASDAQ:ENSG), sold 392 shares of company stock for $67,055 on July 20, 2026, as part of a Rule 10b5-1 trading plan. Despite this sale and recent short-seller allegations regarding compliance and patient care, RBC …

Intensity Therapeutics (INTS) Proxy filing Summary

Intensity Therapeutics (INTS) has released a proxy filing summary for its upcoming virtual annual meeting on June 16, 2026. Shareholders as of April 23, 2026, will vote on proposals including the election of two directors, ratification of the auditor, and amendments to equity plans. …

Co2 Energy Transition Corp - to Accept Redemp

The article states that Co2 Energy Transition Corp will accept relinquishment of a certain asset. No further details are provided in this document.

Intensity Therapeutics (INTS) Q1 2026 earnings summary

Intensity Therapeutics (INTS) reported a Q1 2026 net loss of $2.4 million, an improvement from Q1 2025, primarily due to reduced R&D expenses. The company ended the quarter with $10.2 million in cash, supported by recent fundraising and a new ATM facility, but faces …

Bragar Eagel & Squire, P.C. is Investigating The Ensign Group, Inc. on Behalf of Ensign Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating The Ensign Group, Inc. after a short report alleged the company's business model relies on inadequate patient care and gaming quality metrics, leading to understaffing and patient harm. Following the report's publication, Ensign Group's stock price fell …

Nano Dimension (NNDM) Appoints New Interim CEO and Chairman

Nano Dimension (NNDM) announced the appointment of Moshe Rozenbaum as interim CEO and Phillip Borenstein as chairman of the board, effective immediately. These leadership changes are aimed at navigating strategic initiatives and enhancing operational effectiveness. The company, operating in hardware solutions for advanced manufacturing, …

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

Nano Dimension Ltd. has announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer, effective immediately. Additionally, Phillip Borenstein has been appointed as Chairman of the Board. These appointments aim to ensure business continuity and evaluate strategic priorities to maximize shareholder value during …

Kaplan Fox is Investigating The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media titled “Ensign: The Nursing Home Empire Built On Fatal Neglect.” The report alleges that Ensign provides inadequate care and manipulates …

CO2 Energy Transition Corp. Announces Shareholder Approval of SPAC Extension and Deadline for Acceptance of Redemption Reversals

Houston, TX, July 21, 2026 (GLOBE NEWSWIRE) -- CO2 Energy Transition Corp. (Nasdaq: NOEM) today announced that shareholders have approved all of the proposals that were considered at the shareholder meeting that took place today including a proposal to extend the deadline by which …

Nano Dimension Ltd. SEC Filing (Jul 21, 2026)

Nano Dimension Ltd. announced a settlement agreement with Murchinson Ltd., leading to the withdrawal of Murchinson's proxy solicitation and the cancellation of an extraordinary general meeting. As part of the agreement, four directors resigned from Nano Dimension's board, and three new directors were appointed. …

Insight Enterprises Inc. (IEI) Q3 2024 Earnings Report - Results, Call & Slides

Insight Enterprises Inc. (IEI) reported its Q3 2024 earnings, missing both EPS and revenue expectations. The company recorded an actual EPS of €1.92 against a consensus of €2.02, and actual revenue of €1.83B compared to an expected €1.96B, marking a year-over-year revenue decline of …

Form 13D/A Nano Dimension Ltd. For: 21 July By Investing.com

This article from Investing.com announces the filing of Form 13D/A for Nano Dimension Ltd. on July 21. The content primarily lists various market data, financial instruments, and popular articles, with the core subject being the SEC filing. The article provides no further details beyond …

Ensign Energy Services Inc. - Second Quarter 2026 Earnings Conference Call and Webcast

Nano Dimension Taps Interim CEO as Board Reviews Priorities

Ensign Energy Services (TSE:ESI) Stock Price Crosses Above 200-Day Moving Average - Here's Why

Nano Dimension (NNDM) investors report 8.1% stake and board settlement

Murchinson Ltd. and affiliated entities reported an updated beneficial ownership of 8.1% in Nano Dimension Ltd. after agreeing to a settlement. This agreement led to the resignation of four directors and the appointment of three new directors, and the withdrawal of the investors' demand …

Intensity Therapeutics (INTS) director awarded 5,500 stock options at $4.90

Intensity Therapeutics, Inc. (INTS) director Emer Leahy was granted 5,500 stock options at an exercise price of $4.90 per share. These options will vest in four equal annual installments starting July 16, 2026, and will expire on July 16, 2036. This transaction reflects equity …

Intensity Therapeutics (INTS) awards CFO 34,000 stock options at $4.90

Intensity Therapeutics has granted its Chief Financial Officer, Joseph Talamo, 34,000 stock options with an exercise price of $4.90 per share. These options, which expire on July 16, 2036, will vest in four equal annual installments starting July 16, 2027, contingent on his continued …

Nano Dimension (NNDM) Restructures Board Following Investor Agreement

Nano Dimension (NNDM) has restructured its board effective July 20, 2026, following an agreement with activist investor Murchison, which owns 7.4% of the company. CEO Dave Stehlin, board chairman Robert Pons, and directors Joshua Rosensweig and Andrew Sriubas have stepped down, replaced by Moshe …

Advansix stock trades near yearly low as lower nylon demand weighs on earnings

Advansix Inc. stock is trading near its yearly low due to a tougher chemical cycle, with decreased nylon and ammonium sulfate demand leading to lower revenue and profit in 2023. The company reported a significant drop in revenue to $1.63 billion and net income …

Kaplan Fox Alerts The Ensign Group, Inc. (ENSG) Investors to an Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. (ENSG) following a report by Hunterbrook Media alleging inadequate care and systematic misrepresentations. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock price …

Press Release: Insight Enterprises, Inc. to Report Second Quarter 2026 Financial Results on August 6, 2026

Insight Enterprises, Inc. (NASDAQ: NSIT) announced it will report its second quarter 2026 financial results on Thursday, August 6, 2026. The company will also host a conference call and live webcast to discuss these results.

Ensign Group (ENSG) insider Agwunobi plans 392-share NASDAQ stock sale

Ensign Group insider John O. Agwunobi has filed a notice to sell 392 common shares of ENSG stock through Fidelity Brokerage Services LLC on NASDAQ on July 20, 2026, with an estimated value of $67,055.52. The filing also detailed restricted stock vesting events totaling …

Four Nano Dimension directors resign; Murchinson nominees join board

Nano Dimension and Murchinson Ltd. have reached a settlement agreement, leading to the cancellation of Nano Dimension's July 31, 2026, Extraordinary General Meeting. Under the terms of the agreement, four incumbent directors resigned, and three Murchinson-nominated directors were appointed to Nano Dimension's board. This …

Press Release: Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company's Board of Directors

Nano Dimension and Murchinson Ltd. have reached an agreement to reconstitute Nano Dimension's Board of Directors. The agreement includes the immediate appointment of two new independent directors proposed by Murchinson and a third independent director to be appointed mutually within 45 days. This resolution …

Sensient Technologies (SXT) Q2 2026 Preview: EPS Est. $1.03, Reports July 24

Sensient Technologies (SXT) is expected to report Q2 2026 earnings of $1.03 per share on revenue of $448.9 million, representing significant year-over-year growth. While analyst EPS estimates have seen a slight downward revision in the last 30 days, they are up over the 90-day …

Nano Dimension and activist investor Murchison complete overhaul to board; CEO exits

Nano Dimension and activist investor Murchison have reached an agreement to overhaul Nano's board of directors and the CEO position, leading to the departure of CEO Dave Stehlin and several directors. This move is aimed at aligning the company's strategy with shareholder interests and …

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader Offering 27% Potential Upside

The Ensign Group, Inc. (ENSG) is a prominent healthcare provider with a $10.01 billion market cap, specializing in skilled nursing, senior living, and rehabilitative services. Analysts project a potential upside of 27.16% for ENSG, with an average target price of $217.80, driven by strong …

Enterprise value to revenue forward of Insight Molecular Diagnostics Inc. – NASDAQ:IMDX

This article provides financial information for Insight Molecular Diagnostics Inc. (NASDAQ: IMDX), specifically focusing on its enterprise value to revenue forward. The content, sourced from TradingView, indicates a market closed status with no trades and highlights financial data from ICE Data Services and FactSet. …

Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)

Intensity Therapeutics has restarted patient treatment in its Phase 2 INVINCIBLE-4 Study for triple-negative breast cancer (TNBC) in Switzerland, after a temporary pause to address skin irritation issues. The trial, using INT230-6 before standard-of-care immunotherapy-chemotherapy, aims to improve pathological complete response rates in patients …

Securities Fraud Investigation Into The Ensign Group, Inc. (ENSG)

Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into The Ensign Group, Inc. (ENSG) following reports alleging inadequate patient care and systematic misrepresentations. The investigation was prompted by a Hunterbrook Media report claiming Ensign's business model relies on delivering inadequate …

ETFs Investing in Ensign Group, Inc. Stocks

This article lists a comprehensive selection of Exchange Traded Funds (ETFs) that hold stocks of Ensign Group, Inc. It provides detailed financial metrics for each ETF, including market value, weight, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, and 3-year …

ETFs Investing in Advansix, Inc. Stocks

This article lists various ETFs that hold Advansix, Inc. (ASIX) stocks, presenting a tabular overview of each fund's market value, weight of ASIX in its holdings, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV …

Nano Dimension ends headquarters lease, expects $25M net cash savings

Nano Dimension (NNDM) announced it has terminated its headquarters lease in Ness Ziona, Israel. The 3D printing company expects this move to result in approximately $25 million in net cash savings over the remaining seven-year lease period, including a $5.5 million one-time cash payment …